HELIOS BIOELECTRONICS

Founded in 2016, Helios Bioelectronics, Inc. is developing an application-driven and highly sensitive BioFET platform, enabling real-time monitoring of health status for precision medicine. The platform serves to collect information such as biologically significant genetic aberrations and altered protein expressions to establish dynamic profiling of the molecular regulations for monitoring and diagnostics of complex diseases... BioFET chips generate data that can be readily digitized and transmitted through Cloud computing for AI analysis. Together with the portable-size equipment, Helios aims to take up the rapid growing markets of POCT and molecular diagnostics for personalized and decentralized digital healthcare... Helios Companies with innovative biomarker detection technology as the core, providing clinical diagnosis, academic research product development, and detection system development.

Also known as: Helios Bioelectronics, Inc.

Primary location: Hsinchu Taiwan